FOXO1 and obesity due to melanocortin 4 receptor deficiency: Hepatic insulin resistance in the context of obesity increases the nuclear localization of FOXO1 and the expression of its gluconeogenic and lipogenic gene targets (303), driving up VLDL-TAG secretion (304).